Insufficient scRNA-seq data for expression of UGT1A7 at single-cell level.
Insufficient scRNA-seq data for expression of UGT1A7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 39% | 511.93 | 558 / 1445 | 30% | 6.12 | 55 / 183 |
bladder | 38% | 31.05 | 8 / 21 | 11% | 0.85 | 54 / 504 |
skin | 36% | 30.42 | 648 / 1809 | 1% | 0.03 | 6 / 472 |
adrenal gland | 28% | 29.75 | 73 / 258 | 7% | 0.46 | 15 / 230 |
kidney | 30% | 15.02 | 27 / 89 | 3% | 0.21 | 24 / 901 |
tonsil | 0% | 0 | 0 / 0 | 27% | 1.82 | 12 / 45 |
lung | 1% | 0.54 | 4 / 578 | 20% | 6.99 | 232 / 1155 |
intestine | 12% | 5.15 | 113 / 966 | 2% | 0.10 | 9 / 527 |
uterus | 1% | 0.99 | 2 / 170 | 11% | 2.19 | 49 / 459 |
liver | 5% | 2.60 | 11 / 226 | 3% | 0.38 | 12 / 406 |
prostate | 5% | 3.36 | 13 / 245 | 0% | 0.00 | 1 / 502 |
stomach | 2% | 1.89 | 7 / 359 | 1% | 0.01 | 3 / 286 |
breast | 0% | 0.14 | 1 / 459 | 3% | 0.22 | 29 / 1118 |
adipose | 1% | 0.70 | 16 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.02 | 2 / 178 |
muscle | 0% | 0.10 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
brain | 0% | 0 | 0 / 2642 | 0% | 0 | 0 / 705 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0 | 0 / 430 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
thymus | 0% | 0 | 0 / 653 | 0% | 0 | 0 / 605 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0052697 | Biological process | xenobiotic glucuronidation |
GO_0051552 | Biological process | flavone metabolic process |
GO_0001889 | Biological process | liver development |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0009804 | Biological process | coumarin metabolic process |
GO_0052696 | Biological process | flavonoid glucuronidation |
GO_0042573 | Biological process | retinoic acid metabolic process |
GO_0052695 | Biological process | cellular glucuronidation |
GO_0008210 | Biological process | estrogen metabolic process |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0015020 | Molecular function | glucuronosyltransferase activity |
GO_0019899 | Molecular function | enzyme binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0004857 | Molecular function | enzyme inhibitor activity |
GO_0001972 | Molecular function | retinoic acid binding |
Gene name | UGT1A7 |
Protein name | UDP glucuronosyltransferase family 1 member A7 UDP-glucuronosyltransferase 1A7 (UGT1A7) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-7) (UDPGT 1-7) (UGT1*7) (UGT1-07) (UGT1.7) (UDP-glucuronosyltransferase 1-G) (UGT-1G) (UGT1G) UDP-glucuronosyltransferase UGT1A7 UGT1A7 protein UDP-glucuronosyltransferase (EC 2.4.1.17) |
Synonyms | GNT1 UGT1 |
Description | FUNCTION: [Isoform 1]: UDP-glucuronosyltransferase (UGT) that catalyzes phase II biotransformation reactions in which lipophilic substrates are conjugated with glucuronic acid to increase the metabolite's water solubility, thereby facilitating excretion into either the urine or bile . Essential for the elimination and detoxification of drugs, xenobiotics and endogenous compounds . Catalyzes the glucuronidation of endogenous estrogen hormone epiestradiol . Also catalyzes the glucuronidation of the isoflavones genistein, daidzein, glycitein, formononetin, biochanin A and prunetin, which are phytoestrogens with anticancer and cardiovascular properties . Involved in the glucuronidation of the AGTR1 angiotensin receptor antagonist caderastan, a drug which can inhibit the effect of angiotensin II . Involved in the biotransformation of 7-ethyl-10-hydroxycamptothecin (SN-38), the pharmacologically active metabolite of the anticancer drug irinotecan . Also metabolizes mycophenolate, an immunosuppressive agent . .; FUNCTION: [Isoform 2]: Lacks UGT glucuronidation activity but acts as a negative regulator of isoform 1. . |
Accessions | Q9H3G2 Q5DSZ7 Q9H3G0 Q96PN9 Q96DH9 Q96PP0 Q5K673 Q5K674 ENST00000373426.4 [Q9HAW7-1] Q5K632 H0Y8D7 Q96PP1 Q9HAW7 ENST00000485022.1 Q4R0Z5 Q9H3G1 Q5K672 |